Home › NDC Lookup › RxCUI directory › RxCUI 198742

Magnesium salicylate 580 MG Oral Tablet — RxCUI 198742

RxNorm drug concept · Semantic clinical drug
RxCUI 198742 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 11 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI198742
Official nameMagnesium salicylate 580 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmagnesium salicylate 580 MG (as magnesium salicylate anhydrous 467 MG) Oral Tablet
FDA products mapped6
Package NDCs mapped11
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Magnesium salicylate 580 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Magnesium salicylate 580 MG Oral Tablet RxCUI 198742

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Magnesium salicylate 52364
  2. Brand names 3

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Doans 151653
    • Nuprin Backache 218815
    • Percogesic Backache 1233713
  3. Dose forms 15

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Magnesium salicylate Oral Tablet 375862
    • Magnesium salicylate Oral Product 1158045
    • Magnesium salicylate Pill 1158046
    • Magnesium salicylate Oral Tablet [Doans] 830387
    • Magnesium salicylate Oral Tablet [Nuprin Backache] 809585
    • Magnesium salicylate Oral Tablet [Percogesic Backache] 1233715
    • Doans Oral Product 1173177
    • Doans Pill 1173178
    • +7 more in this family
  4. Clinical & branded drugs 7

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 19 of 26 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Magnesium salicylate 580 MG SCDC · 331420
  • Magnesium salicylate Oral Tablet SCDF · 375862
  • Magnesium salicylate Oral Product SCDG · 1158045
  • Magnesium salicylate Pill SCDG · 1158046

Brand-Name Concepts

  • Magnesium salicylate 580 MG Oral Tablet [Doans] SBD · 830388
  • Magnesium salicylate 580 MG Oral Tablet [Percogesic Backache] SBD · 1233718
  • Magnesium salicylate 580 MG Oral Tablet [Nuprin Backache] SBD · 995942
  • Magnesium salicylate 580 MG [Doans] SBDC · 830386
  • Magnesium salicylate 580 MG [Nuprin Backache] SBDC · 995941
  • Magnesium salicylate 580 MG [Percogesic Backache] SBDC · 1233714
  • Magnesium salicylate Oral Tablet [Doans] SBDF · 830387
  • Magnesium salicylate Oral Tablet [Nuprin Backache] SBDF · 809585
  • Magnesium salicylate Oral Tablet [Percogesic Backache] SBDF · 1233715
  • Doans Oral Product SBDG · 1173177

📦 FDA Products & Package NDCs

6 products · 11 package NDCs
11 package NDCs map to RxCUI 198742 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
47682-0074-36 75 PACKET in 1 BOX (47682-074-36) / 2 TABLET, FILM COATED i... Medique Back Pain Relief Unifirst First Aid Corporation 2022-12-12
47682-0074-80 40 PACKET in 1 BOX (47682-074-80) / 2 TABLET, FILM COATED i... Medique Back Pain Relief Unifirst First Aid Corporation 2022-09-26
47682-0074-99 2 TABLET, FILM COATED in 1 PACKET (47682-074-99) Medique Back Pain Relief Unifirst First Aid Corporation 2022-09-26
47682-0747-33 50 PACKET in 1 BOX (47682-747-33) / 2 TABLET, FILM COATED i... Medique at Home Back Pain Relief Unifirst First Aid Corporation 2022-09-26
47682-0747-99 2 TABLET, FILM COATED in 1 PACKET (47682-747-99) Medique at Home Back Pain Relief Unifirst First Aid Corporation 2022-09-26
55741-0224-24 1 BOTTLE in 1 BOX (55741-224-24) / 24 TABLET in 1 BOTTLE Doans Extra Strength Dr. Reddy's Laboratories Inc. 2016-05-24
55741-0600-01 1 BOTTLE in 1 CARTON (55741-600-01) / 100 TABLET in 1 BOTTL... Doans Maximum Strength Dr. Reddy's Laboratories Inc. 2025-02-01
55741-0600-30 1 BOTTLE in 1 CARTON (55741-600-30) / 30 TABLET in 1 BOTTLE Doans Maximum Strength Dr. Reddy's Laboratories Inc. 2026-05-01
55741-0600-34 3 BLISTER PACK in 1 CARTON (55741-600-34) / 8 TABLET in 1 B... Doans Maximum Strength Dr. Reddy's Laboratories Inc. 2025-02-01
63029-0051-48 1 BOTTLE in 1 CARTON (63029-051-48) / 48 TABLET, COATED in... Percogesic Medtech Products Inc. 2010-01-05
84269-2550-02 50 PACKET in 1 BOX (84269-2550-2) / 2 TABLET, FILM COATED i... Back Pain Relief Extra Strength Doans Wildman Business Group 2024-07-01
Observed labelers: Unifirst First Aid Corporation (5) · Dr. Reddy's Laboratories Inc. (4) · Medtech Products Inc. (1) · Wildman Business Group (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.